Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 9;7(1):43.
doi: 10.1038/s41392-022-00913-3.

ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants

Affiliations

ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants

Jianxia Ou et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
3E8 suppressed SARS-CoV-2 Omicron and Delta variants. Binding of different S1-subunits and 3E8 to hACE2 protein as measured by a ELISA and b BLI. c Bindings of different S1-subunits to HEK293/hACE2/EGFP and Vero E6 cells by flow cytometry. 3E8 blocked the binding of different S1-subunits to hACE2 by d ELISA and e HEK293/hACE2/EGFP cells by flow cytometry. f 3E8 blocked infections of HEK293/hACE2/EGFP cells by pseudo-typed coronaviruses. g 3E8 suppressed live Delta VOC infection in a prophylactic mouse model of COVID-19. RBD-targeting ACE2-Ig and isotype were used as positive and negative controls, respectively. h H&E staining of lung organ samples from different groups. ACE2-Ig- and isotype-treated mice developed serious interstitial pneumonia characterized by a large area of alveolar septal thickening (black arrow) and a large amount of inflammatory cell infiltration (red arrow) coupled with macrophage infiltration (yellow arrow). In contrast, less inflammatory cell infiltration (red arrow) was observed in the lungs of 3E8-treated mice. The scale represents 100 μm. i body weight changes. ***P < 0.001; ****P < 0.0001; ns, not significant

Similar articles

Cited by

References

    1. Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature10.1038/s41586-021-04388-0 (2021). - PubMed
    1. Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature10.1038/s41586-021-04385-3 (2021). - PMC - PubMed
    1. Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature10.1038/s41586-021-04389-z (2021). - PubMed
    1. Connor BA, et al. Monoclonal antibody therapy in a vaccine breakthrough SARS-CoV-2 hospitalized Delta (B.1.617.2) Variant Case. Int. J. Infect. Dis. 2021;110:232–234. doi: 10.1016/j.ijid.2021.07.029. - DOI - PMC - PubMed
    1. Chen Y, et al. ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduct. Target Ther. 2021;6:315. doi: 10.1038/s41392-021-00740-y. - DOI - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts